Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection

Med J Aust. 2021 Apr;214(6):279-280. doi: 10.5694/mja2.50963. Epub 2021 Mar 3.

Authors

David R Darley^{1

2}, Gregory J Dore^{1

3}, Lucette Cysique^{4

5}, Kay A Wilhelm^{1

6}, David Andresen^{1

6

7}, Katrina Tonga^{1

2

7}, Emily Stone^{1

2}, Anthony Byrne^{1

2}, Marshall Plit^{1

2}, Jeffrey Masters⁴, Helen Tang⁴, Bruce Brew^{1

4}, Philip Cunningham⁴, Anthony Kelleher^{1

3}, Gail V Matthews^{1

3}

Affiliations

¹ St Vincent's Hospital, Sydney, NSW.
² St Vincent's Clinical School, University of New South Wales, Sydney, NSW.
³ Kirby Institute, University of New South Wales, Sydney, NSW.
⁴ Institute for Applied Medical Research, St Vincent's Hospital, Sydney, NSW.
⁵ University of New South Wales, Sydney, NSW.
⁶ The University of Notre Dame Australia, Sydney, NSW.
⁷ The University of Sydney, Sydney, NSW.

No abstract available

Keywords: COVID-19; Lung diseases; Neurocognitive disorders; Signs and symptoms; Virology.

Publication types

Letter

MeSH terms

Australia
COVID-19 / complications*
COVID-19 / diagnosis
COVID-19 / physiopathology
COVID-19 / therapy*
Female
Follow-Up Studies
Hospitalization
Humans
Lung / physiopathology
Male
Middle Aged
Prognosis
Prospective Studies
Quality of Life
SARS-CoV-2
Symptom Assessment